New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ranitidine hydrochloride 335mg equivalent to 300 mg ranitidine - film coated tablet - 300 mg - active: ranitidine hydrochloride 335mg equivalent to 300 mg ranitidine excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc   purified water titanium dioxide - indicated for the treatment of duodenal ulcer, and benign gastric ulcer, including that associated with non-steroidal anti- inflammatory agents.

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - clarithromycin - film coated tablet - 250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

peckforton pharmaceuticals ltd - dicyclomine hydrochloride aluminium hydroxide gel magnesium oxidum leve dimeticone, activated - oral suspension - per cent

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - midazolam hydrochloride - solution for injection/infusion - 5 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Ireland - English - HPRA (Health Products Regulatory Authority)

fannin limited - paclitaxel - concentrate for soln for inf - 6 mg/ml - taxanes

Ireland - English - HPRA (Health Products Regulatory Authority)

primecrown ltd. - ranitidine hydrochloride - coated tablets - 300 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - ranitidine - coated tablets - 75 milligram

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - orphenadrine hydrochloride - coated tablet - orphenadrine hydrochloride 50 mg - anti-parkinson drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg - film coated tablet - 150 mg - active: ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - symptomatic relief of heartburn, dyspepsia and hyperacidity in adults and children over 12 years.

United States - English - NLM (National Library of Medicine)

contract pharmacy services-pa - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine hydrochloride 150 mg - ranitidine tablets are indicated in: 1. short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of rantidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. 2. maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acuter ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. 3. the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). 4. short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. 5. maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out